IV Set Manufacturing in Egypt: A Strategic Guide for Medical Device Enterprises

Discover how to establish an IV set manufacturing facility in Egypt, covering medical-grade raw material selection, injection molding, tubing extrusion, component assembly, cleanroom requirements, sterilization, and sterile packaging. Learn how Egyptian Drug Authority (EDA) registration, ISO 13485 quality management, ISO 10993 biocompatibility testing, ISO 14644 cleanroom standards, sterilization validation, and labeling compliance help manufacturers ensure product safety and expand into regional and international markets.

Published :

August 4, 2026

Updated :

October 23, 2026

Published :

August 4, 2026

Updated :

October 23, 2026

IV Set Manufacturing in Egypt
IV Set Manufacturing in Egypt: Production Process, Cleanroom Assembly, Sterilization, ISO 13485 & EDA Regulatory Compliance
Table of Contents
Picture of by Vyankatesh Dhavale
by Vyankatesh Dhavale

Senior Sales Executive | 3 Years of Experience
Vyankatesh Dhavale holds a Bachelor of Pharmacy (B.Pharm) and an MBA specializing in Operations and Supply Chain Management

Why IV Set Manufacturing Matters in Egypt

The demand for medical disposables, especially intravenous (IV) sets, has grown rapidly across emerging healthcare markets. Egypt, with its expanding hospital infrastructure and strategic geographic position, offers a valuable opportunity for companies involved in IV set manufacturing.

With increasing public and private investment in healthcare services, the need for locally manufactured, high-quality IV sets is rising. For medical device enterprises aiming to establish or expand their manufacturing footprint in North Africa or the Middle East, Egypt serves as a logical and cost-effective hub. Favorable trade agreements, a skilled labor pool, and evolving regulatory support under the Egyptian Drug Authority (EDA) make Egypt an attractive destination for medical manufacturing.

Talk to our experts

Understanding the IV Set: Components and Applications

An IV set is a vital component in modern clinical treatment. It allows controlled delivery of fluids, medications, or nutrients directly into a patient’s bloodstream.

Common Components:

  • Drip chamber – Prevents air from entering the bloodstream and controls fluid flow
  • Roller clamp – Regulates the rate of infusion
  • Flexible tubing – Connects fluid sources to the patient
  • Needle or catheter – Enables vein access
  • Injection port – Allows additional medication to be added safely

Applications:

  • Emergency and critical care
  • Chemotherapy and blood transfusions
  • Post-surgical fluid management
  • Nutritional therapy

IV Set Manufacturing Process in Egypt

IV set manufacturing requires precision engineering, sterile assembly, and strict regulatory adherence. The following summarizes the general manufacturing process in Egypt:

1. Raw Material Selection

  • Medical-grade PVC, polyethylene, or polycarbonate
  • Must comply with ISO 10993 (biocompatibility testing) and EDA material safety requirements

2. Component Fabrication

  • Injection molding for drip chambers, clamps, ports
  • Extrusion of tubing with medical-grade plastic
  • Dimensional control and leak testing

3. Assembly and Cleanroom Standards

  • Assembly lines may be manual, semi-automated, or fully automated
  • Production in ISO Class 8 cleanrooms, as per ISO 14644 standards
  • Sterile components handled under controlled environments

4. Sterilization Methods

  • Ethylene oxide (EtO) sterilization (compliant with ISO 11135)
  • Gamma irradiation (for select product lines, per ISO 11137)

5. Packaging and Labeling

  • Sterile blister packs with validated sealing processes
  • Labels must follow Unique Device Identification (UDI) standards
  • EDA labeling and Arabic language requirements must be fulfilled for local sale

Regulatory Framework for IV Set Manufacturing in Egypt

IV sets are regulated under the Egyptian Drug Authority (EDA), which oversees medical device classification, manufacturing approval, and post-market surveillance.

Key EDA Regulatory Requirements:

  • Device classification: Typically Class IIa, depending on invasiveness and risk profile
  • Product registration with EDA before market release
  • Facility licensing under EDA and Ministry of Health
  • Compliance with ISO 13485 for quality management
  • Clinical evaluation or performance testing reports, where applicable
  • Sterility validation and biological safety testing (ISO 10993)
  • UDI, labeling, and Arabic translation for product identification
  • Import/export licensing, if supplying to foreign markets

Note: For companies targeting international markets, alignment with EU MDR, FDA 21 CFR Part 820, and WHO GMP can enhance global acceptance and fast-track regional expansion.

Why Manufacture IV Sets in Egypt?

1. Strategic Geographic Access

  • Central location for exports to North Africa, Sub-Saharan Africa, and the Middle East
  • Access to global shipping via the Suez Canal
  • Participation in AfCFTA and bilateral agreements with EU countries

2. Operational Cost Advantages

  • Competitive labor costs compared to EU and Gulf markets
  • Free-zone incentives in industrial areas like 10th of Ramadan City and Badr City
  • Reduced logistics cost for local and regional distribution

3. Skilled Workforce

  • Access to trained biomedical engineers and medical device technicians
  • Collaboration opportunities with Egyptian universities and vocational institutes
  • Government-backed programs to support medical device industry growth

     

Ready to set up your IV set manufacturing plant in Egypt?

Schedule a Consultation Today

Operon Strategist’s Role in IV Set Manufacturing in Egypt

At Operon Strategist, we provide expert medical device regulatory consulting to guide your IV set manufacturing operations in Egypt. Our services span across the regulatory landscape, ensuring full compliance with EDA regulations, ISO standards, and international requirements. We also offer services in areas such as FDA 510(k) submissions, CE marking, ISO 15378 certification, and turnkey project solutions. Whether you’re looking to navigate complex market entry processes or ensure the quality of your manufacturing, we are here to support you at every step of the journey.

Explore our other services, including:

With Operon Strategist as your trusted partner, you can confidently establish and scale your IV set manufacturing operations in Egypt, ensuring regulatory compliance and tapping into a growing market.

Accelerate your IV set facility setup and EDA compliance

Contact Operon Strategist Now

FAQ's

The IV set manufacturing process typically includes sourcing medical-grade raw materials, injection molding of plastic components, extrusion of tubing, assembly, leak and flow testing, sterilization, packaging, labeling, and final quality inspection. Each stage should be validated to ensure product safety and consistent performance.

Manufacturers must comply with Egyptian Drug Authority (EDA) regulations and implement an ISO 13485-compliant Quality Management System (QMS). Companies exporting IV sets should also meet the regulatory requirements of their target markets, such as US FDA regulations or the EU Medical Device Regulation (MDR).

An IV set manufacturing plant typically requires injection molding machines, tube extrusion lines, automated assembly equipment, leak and flow testing systems, sterilization equipment (such as EO sterilizers), cleanroom facilities, packaging machines, and quality control instruments.

Yes. Growing healthcare investments, increasing demand for disposable medical devices, and opportunities to supply both domestic and export markets make IV set manufacturing a promising business opportunity in Egypt. Success depends on investing in modern manufacturing technologies, maintaining regulatory compliance, and implementing robust quality management systems.

Picture of Vyankatesh Dhavale
Vyankatesh Dhavale

Senior Sales Executive | 3 Years of Experience
Vyankatesh Dhavale holds a Bachelor of Pharmacy (B.Pharm) and an MBA specializing in Operations and Supply Chain Management, with a minor in Marketing. He brings experience in domestic and international business development, strategic client relationship management, and sales of medical device regulatory consulting and turnkey project services. His expertise includes supporting market entry and regulatory service requirements related to CDSCO registration, EU MDR CE marking, US FDA regulations, and ISO 13485 quality management systems.

Table of Contents

Subscribe Newsletter

Talk to our experts

Talk To Our Experts

Have questions about regulatory compliance? Share your requirements and our experts will help you find the right solution.